Stay updated on BCMA CAR-T in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR-T in Multiple Myeloma Clinical Trial page.

Latest updates to the BCMA CAR-T in Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check32 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been modified, suggesting a change in the presentation or explanation of information.SummaryDifference1.0%
- Check46 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2025-02-25.SummaryDifference0.7%
- Check82 days agoChange DetectedThe page now includes information about BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease, with a new date of 2025-02-25, while the previous mention of the therapy without the plasma cell disease specification has been removed.SummaryDifference7%
- Check104 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check111 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to BCMA CAR-T in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR-T in Multiple Myeloma Clinical Trial page.